The use of quinolones in children and accumulation of data on the pharmacodynamics of these drugs have been limited and delayed by concern regarding their chondrotoxicity. A comprehensive review of the findings in animals compared with the cumulative published findings in children and adolescents (ú7,000 to date) allows the conclusion that such concern is not justified. Prospective controlled studies in children are justifiable in view of a continuing lack of correlation between findings in juvenile animals and those in children and because of the selected therapeutic advantages of the current and newer quinolones.
The first quinolone antibiotic, nalidixic acid, whose use was [13] . These advantages underscore the importance of critically assessing our knowledge of quinolone-induced arthropathy in limited to the treatment of urinary tract infections, was a byproduct of antimalarial research and was approved for use in juvenile animals in the context of actual clinical experience with these agents in children and adolescents treated with these children in March 1964. Subsequent modifications of the chemical structure of this drug led to the development of the contemagents. porary fluoroquinolones. These drugs offered, for the first time, a wide spectrum of activity against gram-negative and gramMethods for the Literature Search positive aerobes; favorable pharmacodynamics, allowing for treatment of systemic infections, including those caused by
The following databases were searched from their date of intracellular pathogens; and the flexibility of either intravenous inception through January 1997: MEDLINE, TOXLINE, and or oral administration.
CANCERLIT (National Library of Medicine); CAB Abstracts A new finding was the potential for all fluoroquinolones to (CAB International); AGRICOLA (Agricultural Online Accause damage to the weight-bearing cartilage of juvenile anicess); BIOSIS PREVIEWS (Biosis); SEDBASE (Side Effects mals; however, the significance of this finding with respect to of Drugs; Elsevier); EMBASE (Electronic Excerpta Medica; children remains unclear. For example, nalidixic acid was Elsevier); International Pharmaceutical Abstracts (American found to cause significant arthropathy in beagle puppies at a Society of Health-System Pharmacists); Life Sciences Collecdose that is only half of that approved for treatment of children tion (Cambridge Scientific Abstracts); AGRIS (Food and Agri- [1] . The drug continues to be used in children ú3 months of culture Organization); Derwent Drug File (Derwent); CA age, and no lasting untoward effects on the skeletal system of SEARCH (Chemical Abstracts Service); and SCISEARCH (Inchildren have been reported in over three decades of use. stitute for Scientific Information). Quinolone or fluoroquinoThe unique appeal of the newer-generation quinolones for lone and human or animal were the initial search terms used to children is the fact that they can be used to treat acute bronchoidentify all relevant citations. The searches were subsequently pulmonary exacerbations in cystic fibrosis patients infected narrowed by limiting to citations with the keywords (1) arthrowith Pseudomonas aeruginosa on an outpatient basis [2, 3] .
path? or joint cartilage or cartilage or skeletal system or joint Other indications for which fluoroquinolones show promise in disease or (2) effect or event or pharmacokinetic or pharmacochildren include treatment of urinary tract infections [4] [18] , guinea pigs [19] , rabbits [1, 20] , and ferrets [21] . Quinolone-induced arthropathy is limited to juvenile animals, except when pefloxacin has been used; this though inconsistently, with some analogues [24] . Although the magnesium concentrations in rat joint cartilage decrease to a nadir at the time of early postnatal growth, coinciding with the clinical manifestation of lameness in dogs resolves despite continued dosing [23] , complete resolution of structural changes period of vulnerability for the seemingly similar magnesium deficiency and quinolone-induced cartilage lesions [50] . in affected cartilage has not been reported. MRI of joints in affected immature rabbits has identified thickened articular cartilage, surface irregularities consistent with ruptured vesicles,
Comparison of Quinolone Pharmacokinetics in Children and separation of opposing articular surfaces, consistent with vs. Animals synovial effusion [25] . After various recovery periods (£17 weeks), healing of quinolone-induced arthropathy is incom-
The pharmacokinetics of quinolones in animals have been well described [51] . Conversely, pharmacokinetic data for chilplete in rats [26] . Microscopic examination has revealed that the lesions also fail to completely resolve in dogs after withdren are limited, and those for neonates are only anecdotal [52 -60] . The results of these studies, most of which were drawal periods of 14 [27] , 30 [24] , or 87 days (one animal) [28] . Results of multiple studies have corroborated the importance of conducted in patients with cystic fibrosis, indicate that systemic clearance of the drugs is faster in young children beyond the weight-bearing forces in determining the location of lesions in dogs [17, 24, 29] .
neonatal period compared with adolescents [58] . This finding has led to recommendations for the use of higher doses of For all of the compounds tested, the quinolone-induced changes in dogs begin exclusively within the intermediate zone ciprofloxacin in patients weighing 14 -28 kg [58, 59] . In general, quinolones are rapidly absorbed from the gastrointestinal of the articular-epiphyseal-cartilage complex [23] . The initial changes are detectable by electron microscopy and consist of tract. However, the bioavailability range is wide, with that of norfloxacin as low as 10% -20% and that of ofloxacin as high cytoplasmic vacuolation and mitochondrial dilatation within the chondrocytes [30] . Cellular changes are followed by formaas 80% -90%. All of the newer compounds except norfloxacin have excellent tissue and intracellular penetration at the recomtion of fissures in the extracellular matrix and subsequent loss of collagen and glycosaminoglycans [17, 31] . The seemingly mended therapeutic doses. Quinolones are generally excreted either predominantly in the urine (often as parent compound) characteristic microscopic changes were formerly believed to be pathognomonic for quinolone-induced arthropathy [32] ; or through the bile, where some of these drugs undergo enterohepatic recirculation. however, selective nutritional deprivation of magnesium [33, 34] and injection of various agents into the joint spaces [35] Extrapolation of pharmacokinetic data across species lines (i.e., from animals to humans, especially to children of different have been shown to produce similar lesions in rats.
Possible mechanisms reported from animal studies. The ages) is complicated by significant interspecies differences. Increasing oral doses in dogs to levels at which chondrotoxicity specific mechanism(s) responsible for the initiation of quinolone-induced arthropathy has not been determined. In vitro is observed produces a corresponding increase in plasma concentrations [22] . Such proportional increases in dose and studies of cartilage from various species have implicated inhibitions of synthesis of either collagen or glycosaminoglycans plasma concentration are similar to those observed in children [61] . Within the ranges that encompass arthropathic doses in [36 -42] . Quinolone-induced oxidative injury to chondrocytes has been described [43, 44] , as have inhibition of chondrocyte rats, however, increasing doses of ofloxacin result in markedly subproportional increases in plasma concentrations [18] . There-DNA synthesis [37, 42, 45] and compromised mitochondrial integrity [41, 42, 45] . It is unclear whether any of the perturbafore, with respect to quinolone pharmacokinetics, humans and dogs share greater similarity than rats share with either of tions listed above are primary or secondary events.
The most recent and, perhaps, most plausible postulate for these species. Comparisons of doses of various quinolones in children with minimum arthropathic doses in dogs have shown the mechanism of quinolone-induced arthropathy involves the chelation of magnesium ions by quinolones, resulting in that the two are poorly correlated [23] . For example, the minimal arthropathic doses of nalidixic acid in dogs is 25 mg/kg, changed function of chondrocyte surface integrin receptors. Signal transduction via integrins seems to play a role in the or one-half the therapeutic dose in children (55 mg/kg) [1] . For ciprofloxacin, the doses are equal, at Ç30 mg/kg [29] , maintenance of the integrity of the cartilage matrix [46, 47] . It has been observed that chondrocytes adjacent to fissures in whereas for trovafloxacin, the minimal arthropathic dose in dogs is 50 mg/(kgrd), or five times the projected maximum articular cartilage in rats dosed with ofloxacin have reduced integrin expression [48] , and this observation was confirmed dose in children of 10 mg/(kgrd) [23] . Despite the propensity for quinolones to cause arthropathy in mice [49] . This hypothesis is further supported by the finding that nutritional magnesium deficiency in juvenile rats induced in animals, information about their concentrations in articular cartilage is surprisingly scant. Studies of articular cartilages articular cartilage lesions that were histologically and ultrastructurally identical to those of quinolone-induced arthropathy from rats dosed with quinolones [32] and femoral head cartilage from adult humans (obtained during hip replacement proce- [33, 34] . The combination of ofloxacin administration and magnesium deficiency produced greater cartilage damage than did dures) receiving ofloxacin therapy [62] revealed that the concentrations of quinolones are higher in cartilage than in plasma. either the drug or the deficiency alone. In addition, the normal / 9c3f$$no82 10-23-97 10:23:00 cida UC: CID Machida et al. [1] demonstrated that minimum arthropathic Case Reports of Suspected Quinolone-Associated Arthralgia in Children and Adolescents doses in dogs were 50 mg/kg and 25 mg/kg for nalidixic acid and norfloxacin, respectively; however, in arthropathic cartiAlthough quinolone arthropathy in juvenile animals has been lages the ranges of concentrations were similar (4.58 mg/g to meticulously characterized, practical and ethical limitations 6.90 mg/g of tissue) and sometimes exceeded the values in have restricted the histological characterization of suspected serum. Studies of levofloxacin in rabbits indicated that concencases of quinolone-induced arthralgia in children. The resultant tration of the drug in articular cartilage initially failed to reach lack of information makes it impossible to interpret suspected the maximum serum concentration [42] . However, the cartilage clinical cases of quinolone-associated arthralgia as being equivconcentration later exceeded the concomitant serum concentraalent to quinolone arthropathy in animals. We review and comtion for a period of 2 -24 hours after dosing, indicating a far ment on published case reports and studies in premature infants, greater exposure of cartilage to the drug than would have been children, and adolescents who were treated with a variety of predicted on the basis of serum concentrations alone.
quinolones. In addition, Kato et al. [42] defined an arthropathic concenJoint swellings or pain concurrent with quinolone therapy tration of levofloxacin in rabbit articular cartilage as §12. [74] . The 10 cases of suspected quinoloneistered to a 17-year-old boy. This boy was receiving the drug associated arthropathy involved five girls and five boys ranging twice daily. Data on concentrations of quinolones in the cartiin age from 14 to 17 years. In seven of these 10 reports, the lage of children, as well as information on concentrations in joint manifestations occurred after treatment with pefloxacin. different strata of cartilage or the possible influence on quinoOnly two of these seven patients were treated for exacerbation lone penetration into cartilage by application and release of of cystic fibrosis -related P. aeruginosa infection. Three of pressure during weight bearing in vivo, are lacking.
the other patients had invasive infections with Staphylococcus aureus, and two had cerebral abscess due to various organisms. Seven of the 10 cases involved pefloxacin patients with a variInfluence of Age and Growth on Quinolone Arthropathy ety of infections (often, but not limited to, cystic fibrosis). Two of the 10 cases involved ciprofloxacin-treated patients with Age is the single most critical factor in the development cystic fibrosis, and one case involved the use of nalidixic acid of quinolone arthropathy in animals. Dogs develop quinolone for treatment of a urinary tract infection. arthropathy when exposed at ages of ú2 weeks or õ8 months Consistent signs and symptoms were joint swelling or pain [24, 64] , whereas rats are susceptible shortly after birth to age that involved one or more joints, usually including the knees 8 weeks [15, 65] . Pefloxacin is the reported exception to the (8 of 10 cases). Analysis of synovial fluid from swollen joints of ''juvenile rule,'' as histologically confirmed arthropathy was seven patients treated with pefloxacin revealed that cell counts produced in both juvenile and adult dogs after prolonged exporanged from normal to elevated (i.e., 120 -3,000/mm 3 ). The sure [66] . Because the period of increased sensitivity to the predominant cell types were monocytes and lymphocytes. Radevelopment of quinolone arthropathy in dogs corresponds diographs, which were obtained in nine cases, did not reveal with the period of maximal growth, a high rate of growth could bone or joint changes during either the acute stages of arthralgia be a contributing factor [23] .
or on follow-up, except in one case [73] . With the exception Whether differences in growth can be incorporated into aniof this one case, complete clinical recovery was observed over mal vs. human risk assessments is unclear. Dogs initially outa period of a few days to 3 months for most patients and over grow children by a wide margin. A beagle pup gains 8 kg a period of ú1 year for one [63] . during the period 1 -6 months of age. In contrast, a child of The exception to these benign observations is the patient similar age gains only 4 kg over the same period. Such differdescribed by Chevalier et al. [73] . This 17-year-old patient ences become even more pronounced when the periods of was continuously treated with pefloxacin over a period of ú2 months. He began to have joint pains and, subsequently, growth from birth to adulthood for animals vs. humans are compared. Assuming a growth span from birth to adulthood swelling of the knees during the first month of continued treatment. His initial source of infection was a perforated of 1 year for a dog and 18 years for a human, a day of growth (and quinolone treatment) for a juvenile dog would correspond appendix, which was complicated by the development of endocarditis because of an atrial septum defect, resulting in a to 18 days of growth for a young child. It is possible that the extremely rapid extrauterine growth rates and nutritional cerebral abscess. Septic emboli to the bones were a distinct possibility despite the fact that cultures performed later were requirements of the skeletons of laboratory animals are an explanation for their relative sensitivity to the chondrotoxic efnegative. Concomitant medications included steroids to reduce brain edema and, later, calcitonin for suspected reflex fects of quinolones.
/ 9c3f$$no82
10-23-97 10:23:00 cida UC: CID sympathetic dystrophy. No baseline radiographic findings ated for the presence of primary changes, the comparability of these cases to those of quinolone arthropathy in animals rewere described, but within 1 month after treatment, the patient had limited range of motion, and there was radiographic evimains uncertain. Adequate evaluation of articular cartilages for the presence of primary changes appears warranted for the dence of cartilage loss in the knees. Arthroscopy and biopsies later showed epiphyseal bone necrosis with attendant fibrosis publication of any future credible cases. MRIs, obtained with a special surface coil on formalin-fixed rabbit limbs, detected of synovium and articular cartilage. The patient later required bilateral knee and right hip replacement.
quinolone-induced changes in articular cartilage [25] . This method would be capable of detecting hypothetical human carIn a child treated with nalidixic acid [67] , only reversible soreness of a wrist (without swelling) was reported during two tilage defects as small as those caused by quinolones in dogs [16, 77] . In the rabbit study [25] , each contrast-weighted image separate courses of treatment. In the two case reports that involved ciprofloxacin therapy in children with cystic fibrosis [68, required an acquisition time of 10 -12 minutes without movements. 70], the joint symptoms did not differ from those that can occur in patients with cystic fibrosis alone as a manifestation of either Nevertheless, adequate histopathologic studies would be the most appropriate technique for detecting cartilage lesions comimmune complex disease or hypertrophic osteopathy [75, 76] . The relationship between pefloxacin therapy, as with the other parable to those in animals with quinolone-induced arthropathy [78] . Ultrasonograms of the knee and hip joints allow detection agents, and the reported joint symptoms [63, 69, [71] [72] [73] 74] has been temporal but is supported by the frequency of the reports.
of articular effusion and measurement of the thickness of the synovia and, sometimes, the cartilage. Therefore, ultrasonograAlthough limited histological evaluations have been described, evaluation of articular cartilage (the site for development of quinphy might be useful for screening purposes before and after quinolone therapy. olone arthropathy in animals) has not been reported.
In the case described by Chevalier et al. [73] , the anatomic and morphological changes were consistent with alternative Review of Series of Children and Adolescents Treated processes involving epiphyseal bone rather than articular cartiwith Quinolones lage. In the case reported by Ollier et al. [69] , examination of a synovial biopsy specimen showed nonspecific changes A total of 31 reports from various multipatient studies have described the use of ciprofloxacin, nalidixic acid, norfloxacin, compatible with chronic or subacute irritation. In the case described by Kesseler et al. [63] (a 17-year-old male with cystic or ofloxacin in ú7,000 skeletally immature patients who did not develop arthralgia beyond the level of severity expected as fibrosis), the resolution of effusion and symptoms in both knees took several months, and mild bony alterations were observed a result of the underlying disease [3, 6 -9, 52, 61, 78 -105] (table 1) . Clinical observations and studies for joint changes on radiographs and MRIs. However, no cartilage lesions were observed, and examination of a synovial biopsy specimen, obcollectively included magnetic resonance imaging for 152 patients, ultrasonography for 55, and histopathology for two. tained 10 months after the onset of symptoms, revealed only nonspecific fibrosis. Bone scintigraphy, performed 1 year after Clinical and other studies for joint changes, performed £6 months (magnetic resonance imaging [88] ), 3 years (magnetic the patient was first given pefloxacin, showed symmetrical uptake at the knee level that was interpreted as unusually marked resonance imaging and histopathology [78] ), 7 years (magnetic resonance imaging [89] ), and 12 years (clinical observation for a patient who was only 18 years old. However, the cartilage of the knees appeared normal by magnetic resonance imaging.
only [80] ) after quinolone treatment, did not show any quinolone-induced effects (table 2) . In addition, none of the evaluated Similarly, follow-up MRIs showed normal results 9 months after pefloxacin-associated arthropathy was detected in the case quinolones (ciprofloxacin, ofloxacin, or nalidixic acid) had negative effects on the linear growth of children. described by Chang [74] . A technetium bone scan also revealed persistent minor abnormalities in this case.
Two multipatient studies of premature infants have been published. In one of these studies [52], ciprofloxacin (10 mg/ In summary, these case reports of quinolone-associated effusion and arthralgia in children and adolescents draw attention kg b.i.d.) was administered to six premature infants; the peak plasma concentrations ranged between 0.15 mg/mL and 0.57 to the possibility that chondrotoxicity will occur during therapy with these drugs. Reports implicating pefloxacin (seven of 10), mg/mL, with a mean concentration of 0.31 mg/mL. On the basis of measurements in two infants with meningitis, the CSF are notably overrepresented. There were no long-term sequelae in any of the patients, with the exception of the one described penetration was Ç60% -70%. Bacteriologic cure and no untoward side effects were observed. In another study [104] , two by Chevalier et al. [73] , in whom etiologies other than pefloxacin therapy cannot be ruled out. Assuming a causal relationship premature infants were treated with ciprofloxacin, and five were treated with pefloxacin. No untoward effects were noted, and in that case, it is also possible that the continuation of pefloxacin treatment for at least 4 more weeks after appearance of there were no differences in weight gain, growth, or increase in head circumference when these infants were compared with symptoms was a contributing factor.
Because the areas of articular cartilage (the first site of quinoanother group of equally ill premature infants during followup at 6-month intervals until age 30 -42 months. lone arthropathy of animals) described above were not evalu-/ 9c3f$$no82 10-23-97 10:23:00 cida UC: CID of occurrence) can be constructed around x number of patients * In this report, the incidence of arthralgia was Ç1.5%; however, we considby the equation x/3. By using this equation for the 7,045 paered the relationship to treatment uncertain because the prevalence of such tients treated with quinolones described in this article, it can symptoms was less than or equal to that for the non-quinolone-treated cystic be concluded with 95% confidence that a maximum risk for fibrosis patient population.
the occurrence of chondrotoxicity, as seen in juvenile animals, would currently be not greater than 1 in 2,348 patients (7,045/ 3) or Ç0.04%. The real number is probably much smaller, A review of the approval studies for norfloxacin use in Japanese children contains 406 cases where norfloxacin was given since we do not know how many more children have received quinolones to date for whom the outcomes have not been pubat various dosages to children whose ages ranged from 2 to 11 years; no arthropathy was observed [61] . In the discussion of lished. that study, anecdotal data about 433 cases of diarrhea in Chinese children, who were treated with norfloxacin without any Summary and Interpretation adverse reactions, are mentioned.
By the end of 1994, there were 1,795 case report forms on Our comprehensive review of published data leads to the conclusion that quinolone arthropathy, as described in juvenile file at the Bayer Corporation (Wuppertal, Germany), with data / 9c3f$$no82 10-23-97 10:23:00 cida UC: CID tions temporally related to quinolone use are reversible epi- 
